Global /Japan /Industrials /Specialty Business Services /4896
chevron_leftBack
K Pharma,Inc. logo

K Pharma,Inc.

4896
TSE: 4896 Delayed
757JPY -0.5%
4.72 USD
As of 13 June 2026, K Pharma,Inc. has a market cap of $55.19M USD, ranking #29877 globally and #2768 in Japan. It ranks #6821 in the Industrials sector, and #791 in the Specialty Business Services industry.
Global Rank
29877
Country Rank
2768
Sector Rank
6821
Industry Rank
791
Key Stats
Market Cap
$55.19MUSD
8.83B JPY
Enterprise Value
$47.04MUSD
7.54B JPY
Net Income (TTM)
-$6.2MUSD
-993.0M JPY
PB Ratio
7.0
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
CEO
Komei Fukushima open_in_new
Employees
20
Founded
2016
Website
kpharma.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.5% -4.6% -7.9% 8.1% 17% 0.7%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
4896
Kファーマ株式会社
ISIN: JP3280900006
Shares Out.:
11.623M1 Shares Float: 2.808M2
TV:
SA:
YF:
GF:
BA:
MS:
757 JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About K Pharma,Inc.

K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is headquartered in Minato, Japan.

Similar Companies

Industry: Specialty Business Services (Japan)
Name
Market Cap diff.
PE
9735
$14.55B
2.33T JPY
26K%
22.1
PAYP
$13.65B
25K%
17.5
4523
$8.11B
1.3T JPY
15K%
30.4
6532
$4.97B
795.87B JPY
9K%
21.0
2331
$3.66B
585.61B JPY
7K%
17.4
4194
$1.87B
300.04B JPY
3K%
17.3
Industry: Specialty Business Services (Global)
Name
Market Cap diff.
PE
SHOP
$158.14B
286K%
129.8
VSURE
$132.68B
114.8B EUR
240K%
-
CTAS
$69.6B
126K%
36.8
REL
$63.78B
47.6B GBP
115K%
23.9
PYPL
$45.83B
83K%
9.4
$41.8B
56.91B CAD
76K%
-
chevron_leftBack